Annual report pursuant to Section 13 and 15(d)

Statements of Cash Flows

v3.20.1
Statements of Cash Flows - USD ($)
 5 Months Ended 12 Months Ended
Dec. 31, 2018
Dec. 31, 2019
Cash flows from operating activities:    
Net income (loss) $ (3,000) $ 1,160,000
Adjustments to reconcile net income (loss) to net cash used in operating activities:    
Interest income retained in Trust Account   (5,523,000)
Changes in operating assets and liabilities:    
Increase in prepaid expenses   (50,000)
Increase in accounts payable   46,000
Increase in accrued liabilities 3,000 2,116,000
Increase in deferred compensation   116,000
Net cash used in operating activities (2,135,000)
Cash flows from investing activities:    
Cash deposited in Trust Account (303,152,000)
Cash withdrawn from Trust Account for taxes 1,337,000
Net cash used in investing activities (301,815,000)
Cash flows from financing activities:    
Proceeds from sale of stock to Sponsor 25,000
Proceeds from sale of stock to Anchor Investor 3,000
Proceeds from Note payable to Sponsor 90,000 210,000
Proceeds from sale of Units to the public   300,150,000
Proceeds from sale of Private Placement Warrants 13,582,000
Payment of underwriting discounts (7,830,000)
Payment of offering costs (109,000) (747,000)
Payment of Note payable to Sponsor (300,000)
Net cash provided by financing activities 6,000 305,068,000
Net increase in cash 6,000 1,118,000
Cash at beginning of period 6,000
Cash at end of period 6,000 1,124,000
Supplemental disclosure of non-cash financing activities:    
Deferred underwriters' compensation 10,179,000
Cash paid for income taxes 1,137,000
Deferred offering costs included in accounts payable and accrued liabilities $ 123,000